Schedule 13G ownership disclosure

DiaMedica Therapeutics Inc

Common Shares, no par value · CUSIP: 25253X207

Event date: 2025-08-14

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Trill AB

    Shares: 7,764,465.00 · Class: 15.02%

  • Jan Stahlberg

    Shares: 7,764,465.00 · Class: 15.02%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-25-087405
Form type
SCHEDULE 13G/A
Filer
DiaMedica Therapeutics Inc.
CIK
CIK 1401040
Filed
Sep 04, 2025
Reporting period
Aug 14, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub